Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2012
12/05/2012CN102812008A Therapeutic agent or preventive agent for urine collection disorder
12/05/2012CN102811739A T Cell Activation Inhibitor, Pharmaceutical Composition Containing Same, And Screening Method For T Cell Activation Inhibiting Substance
12/05/2012CN102811719A Methods Of Administering Pirfenidone Therapy
12/05/2012CN102807613A Secreted protein with chemotactic activity and medicament usage thereof
12/05/2012CN102805868A Method of treatment using ligand-immunogen conjugates
12/05/2012CN102805822A Health care product for alleviating snoring
12/05/2012CN102805821A Traditional Chinese medicine compound used for preventing heatstroke
12/05/2012CN102805754A Purification method of deproteinized calf blood serum extract
12/05/2012CN102258552B Method for preparing angelica dahurica decoction pieces
12/05/2012CN102149682B Preparation methods and uses of 1-(substituted aryl)-5-trifluoromethyl-2-(1H)-pyridone compounds and their salts
12/05/2012CN102056609B Pharmaceutical combination
12/05/2012CN101972481B Macromolecular microcarrier and preparation method thereof
12/05/2012CN101665489B Dehydrosilybin trialky ether and preparation method and medical application thereof
12/04/2012US8324425 Method for producing bicyclic γ-amino acid derivative
12/04/2012US8324346 Bioactive keratin peptides
12/04/2012US8324267 Kinase inhibitors and the use thereof
12/04/2012US8324242 Modulators of ATP-binding cassette transporters
12/04/2012US8324205 Quinazoline derivatives as kinase inhibitors
12/04/2012US8324177 Triterpene compositions and methods for use thereof
12/04/2012US8324176 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
12/04/2012CA2695973C Novel salt of isoquinoline compound and crystal thereof
12/04/2012CA2694401C Polycyclic compound
12/04/2012CA2590204C Amide compounds and thrombopoietin receptor activators
12/04/2012CA2575768C Method for screening toxin neutralizing peptide, stx2 inhibiting peptide and verotoxin neutralizing agent
12/04/2012CA2573479C Effective use method of medicaments and method of preventing expression of side effect
12/04/2012CA2557269C Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
12/04/2012CA2430582C A method for in vitro molecular evolution of protein function
12/04/2012CA2422294C Modulation of il-2- and il-15-mediated t cell responses
12/04/2012CA2222509C Connective tissue growth factor
12/04/2012CA2210484C Composition to ameliorate osteolysis and metastasis
11/2012
11/29/2012WO2012161352A1 Reic-expressing adenovirus vector
11/29/2012WO2012161301A1 Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
11/29/2012WO2012161173A1 Substituted amide compound
11/29/2012WO2012161119A1 Novel spiropiperidine derivative and pharmaceutical product containing same
11/29/2012WO2012160184A1 Immunostimulatory oligodeoxynucleotides
11/29/2012WO2012136224A3 Granulocyte -macrophage colony stimulating factor for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapy
11/29/2012US20120302794 Derivatives of venlafaxine and methods of preparing and using the same
11/29/2012US20120302623 Novel Activation and Transfer Cascade for Ubiquitin
11/29/2012US20120302591 Methods of using 8-carboxamido-2,6-methano-3-benzazocines
11/29/2012US20120302587 Rho-kinase inhibitors
11/29/2012US20120302561 Compounds, Formulations, and Methods of Protein Kinase C Inhibition
11/29/2012US20120302557 Biologically active methylene blue derivatives
11/29/2012US20120302554 Phantom phenomena treatment
11/29/2012US20120302553 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
11/29/2012US20120302533 Derivatives of pyrimido [6,1-a] isoquinolin-4-one
11/29/2012US20120302531 beta-2-Adrenoreceptor Agonists
11/29/2012US20120302493 Cyclic Peptides As G-Protein Coupled Receptor Antagonists
11/29/2012US20120301552 CaSR Antagonist
11/29/2012US20120301438 Reprogramming Blood Cells to Pluripotent and Multipotent Stem Cells
11/29/2012US20120301429 Dac hyp compositions and methods
11/29/2012US20120301424 Cyclodextrin-based polymers for therapeutics delivery
11/29/2012CA2840336A1 Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
11/29/2012CA2834440A1 Immunostimulatory oligodeoxynucleotides
11/28/2012EP2527444A2 Antisense oligonucleotide modulation of stat3 expression
11/28/2012EP2527326A1 Novel compounds having 4-pyridylalkylthio group as substituent
11/28/2012EP2527315A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/28/2012EP2526943A1 Liquid formulation comprising an alpha-2 receptor agonist (e.g. clonidin) and oxybutynin (anti-muscarinic agent) for the treatment of sialorrhoea
11/28/2012EP2526103A1 A process for the preparation of novel porphyrin derivatives and their use as pdt agents and fluorescence probes
11/28/2012EP2525791A2 Special composition for the use thereof as a drug
11/28/2012CN1738829B New 2',5'-oligoadenylic acid analog
11/28/2012CN102803260A Substituted polycyclic carbamoylpyridone derivative
11/28/2012CN102803239A Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
11/28/2012CN102803226A Cycloalkyl-substituted imidazole derivative
11/28/2012CN102802442A Prenatal milk-derived composition for preventing the risk of low birthweight of newborns
11/28/2012CN102796095A Tetrahydroquinoline analogues as muscarinic agonists
11/28/2012CN102796058A Compound having thrombopoietin receptor agonism
11/28/2012CN102793921A Methods for treating tweak-related conditions
11/28/2012CN102793867A Traditional Chinese medicine composition for treating climacteric hectic fever
11/28/2012CN102793753A Health care conditioning oil
11/28/2012CN102793714A Application of mecobalamine and analogue to protein tyrosine phosphatases SHP-1 inhibitor
11/28/2012CN102793665A Flexible nanoliposomes with procyanidine and preparation method for flexible nanoliposomes
11/28/2012CN102036664B Selective subtype alpha 2 adrenergic agents and methods for use thereof
11/28/2012CN102016004B Lactic acid bacterium having effect of lowering blood uric acid level
11/28/2012CN101917990B Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
11/28/2012CN101899039B Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
11/28/2012CN101862456B Remedy
11/28/2012CN101854911B Composition for external use
11/28/2012CN101744837B Preparation method for sinonovacula constricta enzymolysis liquid with diversified bioactivities
11/28/2012CN101703777B Tamper-resistant oral opioid agonist formulations
11/28/2012CN101627021B Prophylactic and/or therapeutic agent for hyperlipemia
11/28/2012CN101617827B Supramolecular composite of isosteviol or derivative thereof and preparation method thereof
11/28/2012CN101331134B Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
11/28/2012CN101279955B N-substituted thiamorpholine derivate as DPP-IV inhibitor and medical use thereof
11/27/2012US8318952 Substituted indole derivatives for the treatment of respiratory diseases
11/27/2012US8318910 IL-13 receptor antibodies
11/27/2012US8318815 Method for treatment of tumors using nordihydroguaiaretic acid derivatives
11/27/2012US8318810 Methods for treating neural cell swelling
11/27/2012US8318748 Cathepsin cysteine protease inhibitors
11/27/2012US8318742 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
11/27/2012US8318721 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/27/2012US8318689 SiRNA-based cancer treatment
11/27/2012US8318666 Use of leptin to treat metabolic abnormalities associated with lipoatrophy
11/27/2012US8318467 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes
11/27/2012US8318213 Aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and amylase inhibitor
11/27/2012US8318186 Use of at least a fatty ester for preparing a composition designed to inhibit 5-α-reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive
11/27/2012CA2569016C Fused heterocyclic compound
11/27/2012CA2530706C 2-amino-bicyclo[3.1.0] hexane-2,6-dicarboxylic ester derivative
11/27/2012CA2467374C Indole-2-carboxamides as factor xa inhibitors
11/27/2012CA2451051C Siglec inhibitors
11/27/2012CA2414247C Cosmetic composition and method comprising a hydroxamate mmpi and a triterpenoid glycoside
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 1564